Accelerating Texas K12 Education: Connecting the real world to the classroom.

For twenty-seven years, Jen Meyer, President of Science Teachers Associations of Texas (STAT) and educator, has been well-versed in education ranging from elementary to special education. Meyer, the coordinator for elementary science, describes her career as an “Interesting and exciting educational career.”Meyer shares that fellow educators she has known have amazed her with the community’s work to keep education alive and growing.

STAT has recently completed its strategic plan. They are looking to address how they can move their organization in the next direction. Covid has allowed STAT to take a step back to reassess and set goals. They want to continue to be a resource for teachers and the community for science education. Meyer shares the platform stat web aims to allow educators to ask questions, find resources, and connect with others who can relate.

Virtual Science instruction has presented many challenges. Meyer shared that people were reaching out regarding this issue.Suggestions such as; workgroups utilize the K-12 framework, which is heavily researched based. By keeping their strategies within the research, they show how science is best instructed. Furthermore, the system reinforces understanding and critical thinking as pillars to science and other situations. Meyers discusses the framework isderived from a three-dimensional approach that encompasses the what, how, and why:

  1. Integrating science and engineering practices to current standards within the community is the ” what.”
  2. Science and engineering practices are the “how.”
  3. The reoccurring themes and concepts are the “why.”

Ultimately STAT wants to utilize a particular concept such as a pattern and weave throughout the different strands of science.” said Meyer.Additionally, the phenomena integrates the approach into real-world connections. Not all science teachers are aware of the advancements made in science teaching. The association is also taking steps in helping to make their conferences accessible for many educators by implementing a hybrid approach.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More